Bilitou, A.
30  results:
Search for persons X
?
2

Treatment gaps in the implementation of LDL cholesterol con..:

Ray, K.K ; Haq, I ; Bilitou, A...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.lanepe.2023.100624.  , 2023
 
?
3

Prevalence and Patient Outcomes of Adult Primary Hyperchole..:

Bilitou A ; Were J ; Farrer A...
https://www.dovepress.com/prevalence-and-patient-outcomes-of-adult-primary-hypercholesterolemia--peer-reviewed-fulltext-article-CEOR.  , 2022
 
?
4

Evaluation of contemporary treatment of high- and very high..:

Ray, K.K ; Haq, I ; Bilitou, A...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.athplu.2021.08.003.  , 2021
 
?
5

Cost-effectiveness of eplerenone in NYHA class II chronic h..:

Athanasakis K ; Bilitou A ; Lee D...
https://www.dovepress.com/cost-effectiveness-of-eplerenone-in-nyha--class-ii-chronic-heart-failu-peer-reviewed-article-CEOR.  , 2016
 
?
6

Xenopus NM23-X4 regulates retinal gliogenesis through inter..:

Mochizuki, T ; Bilitou, A ; Waters, CT...
https://discovery.ucl.ac.uk/id/eprint/48472/1/1749-8104-4-1.pdf.  , 2009
 
?
8

Treatment and low-density lipoprotein cholesterol levels in..:

Heintjes, Edith M ; Anastassopoulou, Anastassia ; Kuiper, Josephina...
https://research.rug.nl/en/publications/7eb5e43b-0228-43ae-8006-19acb0825ae5.  , 2023
 
?
 
?
13

Prevalence and Patient Outcomes of Adult Primary Hyperchole..:

Bilitou, Aikaterini ; Were, John ; Farrer, Archie...
info:eu-repo/semantics/altIdentifier/doi/10.2147/CEOR.S347085.  , 2022
 
?
 
1-15